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Abstract
We studied the interaction of n-octyl-L-D-glucopyranoside-solubilized VIP receptors (VIPR) with wheat germ agglutinin
and found that the addition of the lectin to the detergent extract led to the formation of aggregates that could be pelleted by
high speed centrifugation. Resuspension of the pellet in the presence of the competing trisaccharide, N,NP,NQ-
triacetylchitotriose (TAC), dissociated the lectin from the complex without altering the precipitability of VIPR. The final
pellet (referred to as TAC pellet) contained an average of 12% of total protein and 96% of total VIP binding activity with a
typical rank order of potency for VIP-related peptides. Lipid analysis and electron microscopic examination indicated that
the precipitated material was composed of lipid vesicles. VIPR molecules were shown to be integrally inserted in the
liposomes because they could not be dissociated from the vesicles at pH 11 or with high salt concentration. By comparing the
liposome-associated VIP binding activity in the presence and absence of detergent and by showing accessibility of VIPR to
PNGase F, it was concluded that VIP binding sites were not simply trapped within the reconstituted vesicles but likely
exposed at the external surface of the liposomes. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Reconstitution experiments have contributed to
the understanding of how receptors function and
how their activity can be in£uenced by various fac-
tors such as membrane lipid composition or the ori-
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Abbreviations: CMC, critical micellar concentration; ConA, concanavalin A (Canavalia ensiformis) ; DOPC, dioleoylphosphatidylcho-
line; DSA, Datura stramonium agglutinin; DSS, disuccinimidyl suberate; hGRF, human growth releasing factor; HEMBG, 20 mM Hepes
pH 7.5, 2.5 mM EGTA, 5 mM MgCl2, 1 mg/ml bacitracin and 20% glycerol ; HEMBG/MPI, HEMBG bu¡er containing the following
protease inhibitors: 1 mM iodoacetamide, 1 mM PMSF, 5000 U/ml aprotinin, 1 Wg/ml leupeptin, 1 mM pepstatin and 1 mM orthophe-
nanthrolin; Hepes, N-(2-hydroxyethyl)piperazine-NP-2-ethanesulfonic acid; OG, n-octyl-L-D-glucopyranoside; PACAP, pituitary adenyl-
ate cyclase-activating peptide; PHM, peptide histidine methionine amide; PNGase F, peptide-N4-(N-acetyl-L-glucosaminyl)asparagine
amidase; PS, PC and PE, phosphatidylserine, -choline and -ethanolamine, respectively; TAC, N,NP,NQ-triacetylchitotriose; VIP, vaso-
active intestinal peptide; VIPR, vasoactive intestinal peptide receptor; 125I-VIP, monoiodinated vasoactive intestinal peptide; UEA, Ulex
europaeus agglutinin; WGA, wheat germ agglutinin
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entation of the receptor within the lipid bilayer [1]. In
common practice, detergent extracts are mixed with
the required lipids and vesicles are generated through
the removal of the detergent. Depending on the type,
the removal of detergents can be performed by dial-
ysis, reverse-phase evaporation or gel ¢ltration as
well as by adding an insoluble detergent scavenger
like polystyrene beads or by diluting the suspension
below the critical micellar concentration (CMC) of
the detergent. In the present study, we describe a
lectin-based precipitation method that allowed us to
concentrate and functionally reconstitute the vasoac-
tive intestinal peptide receptor (VIPR) from the hu-
man melanoma cells IGR 39.
VIPR is an integral membrane glycoprotein of 63^
66 kDa belonging to the superfamily of seven hydro-
phobic domain receptors coupled to adenylate cy-
clase via the heterotrimeric G proteins. Based on
the primary sequence data, rat and human VIPR
consist of a polypeptide core of 52^56 kDa (includ-
ing a signal peptide of 30 amino acids) carrying four
potential N-glycosylation sites, three of which are
located in the N-terminal extracellular domain [2^
4]. Early studies from our laboratory indicated that
mature N-glycosylation is required for VIP binding
activity [5] and recently, Couvineau et al. [6] reported
that N-glycosylation of at least two sites is crucial for
correct delivery of the receptor to the plasma mem-
brane. Using the human melanoma IGR 39 cells, we
previously showed that the 63^66 kDa VIP binding
protein could be converted to a 43 kDa species
(based on SDS-PAGE) upon complete de-N-glyco-
sylation and that at least three of the four potential
glycosylations carried N-linked glycans [7].
The present work is a continuation of our previous
e¡orts to evaluate the contribution of lipid environ-
ment [8] and N-glycosylation to receptor function
[5,7]. Deriving advantage from the high avidity of
VIPR towards WGA, we used this lectin to precip-
itate the receptor from an octyl-L-glucoside cell ex-
tract and found that endogenous lipids were also
sedimented along with VIPR and other uncharacter-
ized proteins. Removal of the lectin from the sedi-
mented material led to the reformation of membrane
vesicles as assessed by electron microscopy. Various
analytical approaches were applied in order to deter-
mine association of VIPR with the lipids and to
study binding parameters of the reconstituted VIPR.
2. Materials and methods
2.1. Reagents
N,NP,NQ-Triacetylchitotriose (TAC), WGA, n-oc-
tyl-L-D-glucoside and metrizamide were from Sigma
(St. Louis, MO, USA). Synthetic VIP was purchased
from Neosystem (Strasbourg, France). 125I-VIP (200
Ci/mmole) was iodinated by iodogen method and
puri¢ed by HPLC as previously described [9]. The
bee venom phospholipase A2 was from Boehringer
(Mannheim, Germany) and the cross-linker disucci-
nimidyl suberate (DSS) was from Pierce Chemical
(Rockford, IL). Flavobacterium meningosepticum
PNGase F was from Oxford Glycosystem (Abing-
don, UK). All other chemicals were of the highest
reagent grade available.
2.2. Cell culture
The melanoma cells IGR 39 [10] were cultured in
Dulbecco’s modi¢ed Eagle’s medium (DMEM) con-
taining 10% fetal calf serum. When needed, cell cul-
tures were metabolically labeled overnight in com-
plete media with 100 WCi/ml Tran35S-label (ICN
Biochemicals, Irvine, CA).
2.3. Solubilization and lectin precipitation
Solubilization of IGR 39 cells was performed es-
sentially as described earlier [11]. Brie£y, cells were
harvested in PBS and rinsed twice in the same bu¡er
before solubilization. Cell pellet was then resus-
pended in solubilization bu¡er HEMBG/MPI con-
taining 1% n-octyl-L-D-glucoside (OG), incubated at
4‡C for 30 min with mild stirring followed by cen-
trifugation at 100 000Ug for 1 h in a TL100 Beck-
mann ultracentrifuge. The lectin WGA (0.5 mg/ml,
¢nal concentration) was then added to the
100 000Ug supernatant (OG extract). After 20 min
incubation at 4‡C the clear OG extract became tur-
bid, and a yellowish pellet (WGA pellet) was ob-
tained after another centrifugation at 100 000Ug
for 15 min. In order to wash out the detergent,
the WGA pellet was homogenized 3 times in a de-
tergent-free HEMBG/MPI bu¡er by passing the
suspension through a 25-gauge needle, followed by
centrifugation at 100 000Ug for 15 min. The last
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pellet was treated similarly except that the WGA
competing trisaccharide TAC was included to
dissociate WGA-glycoprotein aggregates and the
mixture was incubated for 15 min at room temper-
ature. A white translucent pellet (TAC pellet) was
obtained after another 100 000Ug centrifugation, re-
suspended in HEMBG/MPI and stored at 4‡C until
use.
2.4. Gel ¢ltration of solubilized VIPR
The OG-extracted VIP binding activity was ana-
lyzed by size-exclusion chromatography. A TSK
Spherogel SW 4000 HPLC column was equilibrated
with HEMBG/MPI containing 0.1% OG. Flow rate
was 0.5 ml/min. The column was calibrated with mo-
lecular mass standards (thyroglobulin, 669 kDa;
apoferritin, 443 kDa; L-amylase, 200 kDa; alcohol
dehydrogenase, 150 kDa and carbonic anhydrase 29
kDa). 500 Wl of OG extract (5.5 mg/ml) were applied
to the column and aliquots of 300 Wl were collected
and analyzed for VIP radioreceptor assay as de-
scribed below.
2.5. VIP radioreceptor assay
125I-VIP binding was determined using the poly-
ethylenimine soaked GF/F glass ¢ber ¢lters and vac-
uum ¢ltration as described earlier [11]. Cross-linking
of 125I-VIP to cells or TAC pellet was performed
using 2 mM DSS [11]. After cross-linking, solubiliza-
tion and reconstitution were performed as described
above.
2.6. Metrizamide density gradient centrifugation
After cross-linking of 125I-VIP to IGR 39 cells and
solubilization, the TAC pellet containing 125I-VIP-la-
beled glycoproteins was prepared as described above
except that WGA pellet was resuspended in the pres-
ence of [14C]DOPC (50 WCi/ml) as a tracer before the
addition of the trisaccharide TAC. This mixture was
then subjected to a discontinuous metrizamide den-
sity gradient as described [12], with slight modi¢ca-
tions. Brie£y, the ¢nal TAC pellet was resuspended
in 1 ml Hepes/NaOH bu¡er pH 7.5 containing MPI
and adjusted to 40% (w/v) metrizamide by the addi-
tion of a 60% metrizamide solution prepared in the
same bu¡er. This solution was transferred into a 13.5
ml polypropylene centrifuge tube. Then 3 ml of 20%
metrizamide was overlaid followed by another over-
lay of 3 ml of 10% metrizamide which, in turn, was
covered with bu¡er (see below). Centrifugation was
carried out at 100 000Ug for 2 h at 25‡C in an SW
41 rotor. After centrifugation, a turbid band could
be seen distinctly at the 40^20% metrizamide inter-
face. Fractions of 500 Wl were collected from the top
to the bottom of the tube and radioactivity was de-
termined.
2.7. SDS-polyacrylamide-gel electrophoresis
SDS-PAGE was performed according to Laemmli
[13] using 1.5 mm thick slab gels containing 10%
acrylamide. When needed for autoradiography, gels
were exposed to Fuji-XR ¢lms at 380‡C.
2.8. Lipid analysis and phospholipase A2 treatment
Lipids were extracted from samples according to
Folch et al. [14] and chromatographed on 0.25 mm
thick silica gel (Merck, Darmstadt, Germany) in
chloroform/methanol/methylamine (68:26:6, v/v).
Lipid spots were visualized using phosphomolybdic
acid (0.05%) in solution in acetic acid/sulfuric acid
(25:1.25, v/v). In the phospholipase A2 experiments,
TAC pellet aliquots were adjusted to 500 Wg protein/
ml in HMBG (20 mM Hepes, 5 mM MgCl2, 1 mg/ml
bacitracin and 20% glycerol) containing MPI. BSA
and CaCl2 were then added to a ¢nal concentration
of 1 mg/ml and 10 mM, respectively. Phospholipase
A2 dissolved in water was then added and samples
were incubated for di¡erent periods at 25‡C. Ali-
quots were then assayed for 125I-VIP binding assay
as described above.
2.9. Electron microscopy
WGA and TAC pellets were ¢xed with 2% gluta-
rdialdehyde in 0.1 M phosphate bu¡er pH 7.4, post-
¢xed with 1% osmium tetroxide, dehydrated through
cold graded ethanol and embedded in Epon. The
sections were then examined with a Jeol 100C micro-
scope. Freeze-fracture electron microscopy was per-
formed on material resuspended from WGA and
TAC pellets, according to Lindstrom et al. [15].
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2.10. PNGase F treatment
125I-VIP-labeled cells and 125I-VIPR-labeled
vesicles (reconstituted from those cells) were incu-
bated with PNGase F (100 U/ml) in 100 mM Tris/
HCl pH 8.6 containing MPI and 10 mM orthophen-
anthrolin. Control samples did not receive the en-
zyme. The reaction mixtures were incubated at
37‡C for 3 h and the samples were analyzed by
SDS-PAGE, after addition of 5-fold concentrated
SDS sample bu¡er.
2.11. Other procedures
The protein content of samples was measured us-
ing the bicinchoninic acid assay (BCA assay, Pierce)
and phosphorus determination was carried out ac-
cording to Van Veldhoven and Mannaerts [16]. The
computer-¢tted program LIGAND [17] was used to
analyze the binding data.
3. Results
3.1. Solubilization and lectin precipitation
The human melanoma IGR 39 cells were chosen
for our solubilization and reconstitution experiments
because these cells have been shown to express a very
high number of VIP receptors [10]. Detergent solu-
bilization was performed in the presence of 1% n-
octyl-L-glucoside which, as described earlier [11],
among several detergents was the most e⁄cient in
extracting active VIP receptors. About 70% of the
initial VIP binding activity could be recovered in
the 100 000Ug supernatant. To further prove the
soluble nature of VIPR, 0.5 ml of OG extract (5
mg/ml protein) was loaded on an SK Spherogel
SW 4000 HPLC column preequilibrated in the solu-
bilization bu¡er containing 0.1% detergent. As
shown in Fig. 1A, speci¢c VIP binding was found
to partition between the void volume (V0) and the
included volume (Vt) with an elution volume corre-
sponding to an apparent molecular mass of 200 kDa
(Fig. 1B). This value is close to the mass of the 125I-
VIP-labeled VIPR we previously characterized on
another cell line, HT 29 cells [11]. This value is sig-
ni¢cantly larger than the 63^65 kDa displayed in
SDS-PAGE by the 125I-VIP-labeled VIPR (this re-
port) and the 52^56 kDa predicted from primary
sequence data [2^4]. This discrepancy may be ex-
plained by the interaction of the receptor with lipids
and detergent molecules. In fact, membrane proteins
typically bind detergent and lipids up to 30^100% of
their weight [18,19]. Alternatively, OG-extracted
Fig. 1. Analysis of detergent-solubilized IGR 39 cells by HPLC
size-exclusion chromatography. (A) A 0.5 ml aliquot of OG ex-
tract was run on a TSK Spherogel SW 4000 column, equili-
brated with HEMBG/MPI containing 0.1% OG and calibrated
with the following standards: thyroglobulin, 669 kDa (A); apo-
ferritin, 443 kDa (B); L-amylase, 200 kDa (C); alcohol dehy-
drogenase, 150 kDa (D); carbonic anhydrase, 29 kDa (E). The
void volume (V0) is de¢ned as the elution volume of blue dex-
tran (2000 kDa) and the total volume (Vt) is de¢ned as the elu-
tion volume of phenol red. (B) Estimation of soluble VIPR mo-
lecular weight. The regression curve was constructed by plotting
the logarithmic values of molecular weights of various marker
proteins (see above) against the distribution coe⁄cient
Kav = (Ve3V0)/(Vt3V0) where Ve is the elution volume of
standard proteins.
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VIPR may form oligomeric receptors which may be
associated to other proteins such as G proteins [20].
Our previous investigations on the glycosylation of
VIP receptor have demonstrated that VIPR bound
avidly to the immobilized lectin WGA and could be
e⁄ciently recovered from the column in the presence
3 mM TAC [5,7]. We took advantage of this high
avidity of VIPR towards WGA to precipitate the
receptor from an OG extract of IGR 39 cells, using
a soluble form of the lectin. After dissociating the
WGA pellet by the trisaccharide TAC, another pellet
was obtained (TAC pellet). As shown in Fig. 2, sev-
eral major proteins present in the original OG extract
(lane 1) were eliminated during the ¢rst WGA pre-
cipitation step (lane 2). However, there was no sig-
ni¢cant di¡erence in protein pattern between WGA
pellet (lane 3) and TAC pellet (lane 5). In fact, only
few proteins including WGA dimer 36 kDa protein
came into solution after the addition of the trisac-
charide TAC (lane 4). This result shows the e⁄cacy
of TAC in dissociating WGA-glycoprotein com-
plexes and indicates that the majority of proteins
precipitated with WGA are hydrophobic glycopro-
teins since they remain precipitable after the removal
of the lectin.
Fig. 3. Lipid analysis of OG extract and TAC pellet. Lipids
(0.3 Wmol) were isolated from the OG extract (lane 1) or the
TAC pellet (lane 2) and chromatographed in chloroform/metha-
nol/methylamine (68:26:6, v/v). Lipid spots were visualized us-
ing phosphomolybdic acid. Reference lipid markers are indi-
cated on the right and the position of OG is indicated on the
left. PE, PC, PS and PI, phosphatidylserine, phosphatidylchol-
ine, phosphatidylethanolamine and phosphatidylinositol, respec-
tively; SM, sphingomyelin.
Fig. 2. SDS-PAGE analysis of proteins from various fractions. After solubilization and WGA/TAC precipitation, samples from vari-
ous fractions were resolved on a 12% acrylamide gel under non-reducing conditions. Lanes: 1, OG extract; 2, WGA supernatant; 3,
WGA pellet ; 4, TAC supernatant; 5, TAC pellet. Reference protein size markers are indicated on the left of the ¢gure.
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3.2. Lipid composition of TAC pellet
In order to check whether precipitated glycopro-
teins were associated with lipids, we analyzed the
lipid content of the TAC pellet vs. OG extract. As
shown in Fig. 3, phospholipids PS, PC and PE, orig-
inally present in the OG extract, were recovered in
the TAC pellet. Since lipids remained associated to
glycoproteins throughout the various centrifugation
steps, this result suggests that solubilization with OG
only partially delipidates glycoproteins which may
explain, in part, the apparent high molecular weight
of VIPR observed by HPLC gel-exclusion chroma-
tography (see above). Attempts to substitute endog-
enous lipids by exogenous phospholipids (PS, PC,
PE, DOPC) with or without cholesterol were met
with limited success and the recovery of active VIP
binding sites was very poor and variable. For in-
stance, the following combination (PE/PS/cholester-
ol, 56:19:25 in mol%) which was successfully used to
reconstitute the OG-solubilized nicotinic acetylchol-
ine receptor nAChR [21] was completely ine⁄cient in
our hands, i.e., less than 10% VIP binding activity
reconstituted (data not shown).
3.3. Electron microscopic examination
Due to the visible turbidity of the TAC suspension
Fig. 4. Electron microscopy of the reconstituted lipid vesicles. Electron microscopic examination of sections from WGA pellet (A) and
TAC pellet (B) (U100 000). (C,D) Electron microscopy of freeze-fracture replicas of material derived from WGA pellet (C) and TAC
pellet (D), (U33 000).
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and given that lipids were present in this fraction, we
carried out electron microscopy on WGA and TAC
pellets to assess whether these fractions were com-
posed of lipid vesicles. As shown in Fig. 4A,B, a
clear di¡erence could be seen between WGA and
TAC pellets. The TAC-sedimented material was
composed of networks having a vineyard-like aspect
suggestive of multilamellar structures, whereas WGA
pellet examination showed a weak supramolecular
arrangement, although some rough shapes could be
seen from place-to-place (Fig. 4A, arrows). Evidence
for this di¡erence was also provided by freeze-frac-
ture electron micrographs (Fig. 4C,D). Freeze-frac-
ture electron microscopy showed the presence of nu-
merous vesicles in the material resuspended from
TAC pellet (Fig. 4D), while no vesicles could be de-
tected in the WGA-precipitated material (Fig. 4C).
Taken together, lipid analysis and electron micro-
scopy suggest that lipid vesicles are formed during
or shortly after the dissociation of lectin from the
precipitated material.
3.4. Functionality of the reconstituted VIP receptor
In a ¢rst set of experiments, 125I-VIP was cova-
lently cross-linked to intact cells in the presence of
2 mM disuccinimidyl suberate and solubilization
with OG was performed as described above. By fol-
lowing the same protocol of WGA/TAC precipita-
tion, the ¢nal TAC pellet and supernatant were an-
alyzed by SDS-PAGE and autoradiography. As
shown in Fig. 5A (lane 2) a 125I-VIP-receptor com-
plex representing the typical 63 kDa VIP binding
protein was predominantly recovered in the TAC
pellet. We then assayed 125I-VIP a⁄nity labeling of
the material recovered in the TAC pellet. Fig. 5B
shows the incorporation of 125I-VIP to a 63 kDa
protein. This incorporation was blocked in the pres-
ence of 0.3 WM unlabeled VIP (Fig. 5B, +).
The pharmacology of the reconstituted VIPR was
therefore investigated by competition between 125I-
VIP and VIP-related peptides. As shown in Fig. 6,
the reconstituted receptor from IGR 39 cells exhib-
Fig. 5. SDS-PAGE of 125I-VIPR. (A) After covalent cross-link-
ing of 125I-VIP to IGR 39 cells, solubilization and reconstitu-
tion of the 125I-VIP-labeled material into lipid vesicles were per-
formed as described in Fig. 1. Samples from the TAC
supernatant (lane 1) and the TAC pellet (lane 2) were then re-
solved on a 12% polyacrylamide gel under reducing conditions.
(B) 125I-VIP was covalently cross-linked to the TAC pellet in
the absence (3) or the presence (+) of 0.3 WM unlabeled VIP.
Gels were then exposed to Fuji-XR ¢lms at 380‡C for autora-
diography.
Table 1
125I-VIP binding parameters of OG-solubilized and reconstituted VIPR
Sample High a⁄nity binding sites Low a⁄nity binding sites
Kd (nM) Bmax Kd (nM) Bmax
OG extract 0.67 þ 0.12 710 þ 250 136 þ 64 7 850 þ 4 560
TAC pellet 0.36 þ 0.04 5 110 þ 320 110 þ 42 136 200 þ 53 000
OG-solubilized or reconstituted VIPR was assayed for 125I-VIP binding in the presence or absence of 0.3 WM unlabeled VIP. The
computer-¢tted program LIGAND [17] was used to analyze binding data. Values represent the mean þ S.E. of three independent ex-
periments performed in duplicate.
Bmax = fmol/mg protein.
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ited pharmacological characteristics consistent with
those observed for the original membranes, VIP -
sPACAPs helodermins hGRF = PHMs secretin
[10]. Glucagon did not interfere with VIP binding
at all. Binding parameters of the reconstituted
VIPR are reported in Table 1. Scatchard analysis
of binding data indicates the presence of two classes
of binding sites: high a⁄nity binding sites with a Kd
of 0.36 þ 0.04 nM and low a⁄nity binding sites with
a Kd of 110 þ 42 nM (Table 1). With regard to high
a⁄nity sites, these Kd values were reproducibly lower
than the corresponding values of 0.67 nM in the OG
extract (this paper) and 0.66 nM on intact cells [10].
These data indicate a slight increase in receptor af-
¢nity upon reconstitution. Moreover, compared to
the OG extract, the binding capacity Bmax (fmol/mg
protein) was increased by 7- and 17-fold in high and
low a⁄nity binding sites, respectively. Re-solubiliza-
tion of the TAC pellet by 1% OG did not lead to an
increase in VIP binding activity indicating that all
VIP binding sites of the reconstituted VIPR were
accessible to the ligand (data not shown).
In another study, we compared the precipitability
of VIP binding activity and [35S]methionine/cysteine-
labeled proteins, with WGA and lectins having dif-
ferent sugar speci¢cities such as concanavalin A
(ConA, speci¢c for mannose), Ulex europeus aggluti-
nin (UEA, speci¢c for fucose) and Datura stramo-
nium agglutinin (DSA, speci¢c for GlcNAc oligomers
and N-acetyllactosamine). As shown in Table 2,
WGA and DSA, which respectively precipitated
12% and 10% of total 35S-labeled proteins, were the
most e⁄cient in precipitating VIP binding activity
(96% and 95%, respectively). However, while ConA
could precipitate up to 32% of total 35S-labeled pro-
teins, it precipitated only 10% of VIP binding activ-
ity. These data suggest that lectin precipitation of
VIPR is sugar-speci¢c and is likely due to a direct
interaction between the lectin and VIPR.
3.5. Association of VIPR with lipid vesicles
In order to ensure that VIPR was truly associated
with the liposomes we used two di¡erent approaches,
involving on one hand a discontinuous metrizamide
gradient centrifugation, and phospholipase A2 treat-
ment on the other hand. In a ¢rst set of experiments,
vesicles containing 125I-VIP-labeled proteins were
prepared in the presence of [14C]DOPC as a lipid
tracer and subjected to a discontinuous metrizamide
gradient (Fig. 7A) as described under the experimen-
tal section. Fig. 7B shows the distribution of
[14C]DOPC and 125I-VIP radioactivity. About 72%
of [14C]DOPC and 78% of 125I-VIP radioactivity
£oated at the same position between 20% and 40%
metrizamide (peak 3). Two small peaks of lower den-
sities were also obtained (peaks 1 and 2); only peak 2
contained 125I-VIP-labeled proteins. Note that the
125I-VIP labeling is dramatically reduced when
Table 2








WGA 12 96 þ 2.5
ConA 32 10 þ 4.0
UEA 8.5 22 þ 5.2
DSA 10 95 þ 3.5
Cells were metabolically labeled with [35S]methionine/cysteine
mixture overnight, solubilized with 1% OG and precipitated
with the indicated lectins. Data are the mean of one representa-
tive experiment performed in triplicate. VIP binding data are
the mean þ S.D. of three independent experiments performed in
duplicate.
a% of TCA-precipitable radioactivity in OG extract.
b% of VIP binding activity in OG extract.
Fig. 6. Competition for 125I-VIP binding by VIP and VIP-re-
lated peptides. Lipid vesicles reconstituted from IGR 39 cells
were incubated with 125I-VIP in the presence of increasing con-
centrations of VIP, PACAP27, helodermin (Hd), hGRF (GRF),
PHM, secretin (Sn) or glucagon (Gluc). Results are expressed
as the percentage of speci¢cally bound radioactivity. Data are
the mean of three independent experiments performed in tripli-
cate. S.E.M. values are 6 10%.
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cross-linking was carried out in the presence of 0.3
WM unlabeled VIP (Fig. 7B, +), indicating that 125I-
VIP-labeled proteins represent VIP receptors. Since
125I-VIP labeling was not displaced in fractions 2 and
3 with the same e⁄ciency, we sought to determine
whether VIPR partition between peaks 2 and 3 could
be explained by structural heterogeneity of the recep-
tor. To this end, samples from peaks 2 and 3 were
analyzed by SDS-PAGE and autoradiography. Fig.
7B (inset) shows that the observed 125I-VIP-labeling
pattern of the gradient corresponds to 125I-VIP-la-
beled VIPR and that no di¡erence could be seen
between receptors from bands 2 and 3, with respect
to their apparent molecular weight. It seems likely
that the WGA/TAC reconstitution technique led to
the formation of di¡erent size vesicles which may
explain the partition of VIPR between a heavy
(peak 3) and a light (peak 2) fraction. Further experi-
ments are needed to clarify this point.
Yet, while this result demonstrates the association
of VIPR with lipid vesicles, it was of importance to
ascertain whether the receptors were merely adsorbed
at the surface or had become incorporated as integral
proteins. To this end, the TAC fraction was divided
in aliquots which were mixed with metrizamide (40%
¢nal concentration) at pH 11 or containing 1 M
NaCl, conditions designed to remove peripheral
(i.e., not integrally inserted) membrane proteins
[22]. As a control, an aliquot was mixed with metri-
zamide containing 1% OG and treated similarly as
the other fractions. Distribution of radioactivity was
then reexamined by discontinuous metrizamide gra-
dient. As shown in Fig. 8, these conditions have no
e¡ect on the pro¢le of the gradient which remained
Fig. 7. Separation of vesicles in a metrizamide density gradient. Vesicles prepared with 125I-VIP-labeled proteins and [14C]DOPC were
centrifuged in a discontinuous metrizamide gradient. After centrifugation, fractions of 500 Wl were collected from the top to the bot-
tom of the tube and radioactivity was determined. (A) Schematic view of the distribution of vesicle populations. (B) Distribution pro-
¢le for phospholipids ([14C]DOPC) and VIPR (125I-VIP) in the presence (+) or the absence (3) of 0.3 WM unlabeled VIP. Inset: auto-
radiogram of SDS-PAGE of 125I-VIP a⁄nity-labeled receptor from peak 2 (lane 2) and peak 3 (lane 3). Experimental details are
described in Section 2.
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roughly identical to the pro¢le of untreated TAC
fraction (Fig. 8A,B). In contrast, when the vesicles
were treated with 1% OG, both [14C]DOPC and 125I-
VIP-labeled material was concentrated in the bottom
of the tube but a large proportion of radioactivity
was randomly distributed throughout the gradient
(Fig. 8C). The failure of the lipids to £oat in the
presence of detergent was most likely the result of
formation of mixed micelles. Because the association
of the 125I-VIP radioactivity with the vesicles was
sensitive to detergent and resistant to alkaline or
high salt treatments, we conclude that VIP receptors
were integrally inserted in the lipid bilayers.
To further ensure that VIPR is present in the TAC
pellet as a lipid-associated protein rather than as an
insoluble aggregate which retains activity, we studied
the e¡ect of phospholipase A2 on VIP binding. Lipid
dependence of VIPR function has been reported ear-
lier by our group [8]. In fact, we found that pertur-
bation of membrane £uidity of HT 29 cells by exog-
enous short acyl chain phospholipids abolished VIP
binding activity [8]. In the present study we demon-
strated that 125I-VIP binding to the reconstituted
membranes was diminished by 20% after preincuba-
tion with 1 IU/ml of phospholipase A2, and by 40%
at an enzyme concentration of 10 IU/ml (Fig. 9).
Since phospholipase A2 has been reported to hydro-
lyze organized lamellar structures of phospholipids
[23], this result strongly suggests that VIPR function
is dependent on the organization of surrounding
phospholipids. Furthermore, given that VIPR has
seven transmembrane (lipophilic) domains, it may
cross several times the lipid bilayer of the reconsti-
tuted vesicles to be correctly folded and functional.
3.6. PNGase F-deglycosylation of the reconstituted
VIPR
PNGase F is an endoglycosidase cleaving most
common mammalian N-linked oligosaccharides at
the N-glycosidic bond [24]. It has been reported
that human VIPR carries four potential N-glycosyla-
tion sites, three of which are located in the N-termi-
nal extracellular domain [4] and we have previously
demonstrated that the human VIPR is heavily N-gly-
cosylated [5,7,25]. Our previous data have demon-
Fig. 9. 125I-VIP binding to phospholipase A2-treated mem-
branes. Solubilization and WGA/TAC precipitations were per-
formed as described in Section 2. Phospholipase A2 was added
to aliquots of TAC pellet at the indicated ¢nal concentrations
and samples were incubated for di¡erent periods at 25‡C.
100 Wg/ml aliquots were then assayed for 125I-VIP binding assay
as described above. Results are expressed as the percentage of
speci¢cally bound radioactivity. Data are the mean of two inde-
pendent experiments performed in duplicate.
Fig. 8. Insertion of VIPR into liposomal bilayer. Vesicles were
prepared with 125I-VIP-labeled proteins and [14C]DOPC, sub-
jected to various dissociation conditions during density gradient
centrifugation performed as in Fig. 7. (A) Vesicles treated with
1 M NaCl in 20 mM Hepes/NaOH bu¡er pH 7.5. (B) Vesicles
treated with 20 mM Hepes/NaOH pH 11. (C) Vesicles treated
with 1% OG in 20 mM Hepes/NaOH bu¡er pH 7.5. All bu¡ers
contained protease inhibitors (MPI).
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strated that under chaotropic conditions, i.e., in the
presence of SDS and L-mercaptoethanol, the 63 kDa
VIP binding protein could be converted by PNGase
F into a 43 kDa species presumed to be the fully
deglycosylated receptor. Under native conditions,
however, only a partial deglycosylation of VIPR
could be observed either with intact cells or mem-
brane preparations, suggesting an inaccessibility of
some N-glycosidic bonds to the enzyme [7].
In order to get further insight into the molecular
characteristics of the reconstituted VIPR, we inves-
tigated their sensitivity to PNGase F de-N-glycosyla-
tion. To this end, 125I-VIP was cross-linked to intact
cells and PNGase F-deglycosylation was performed
under native conditions either directly on 125I-VIP-
labeled cells or on 125I-VIP-labeled lipid vesicles re-
constituted from those cells. Fig. 10 shows that the
molecular mass of the cellular VIPR was shifted to
53 kDa whereas, under the same conditions, the re-
constituted receptor was converted into the fully de-
glycosylated 43 kDa protein. Interestingly, all the
reconstituted VIPR were converted by PNGase F,
since no trace of labeled material remained at the
position 63 kDa. These data may indicate that native
and reconstituted VIPR may be in di¡erent lipid en-
vironments or di¡erently embedded in the lipid bi-
layer and hence, di¡erently accessible to the enzyme
PNGase F.
4. Discussion
Our previous investigations on the glycosylation of
VIP receptor have demonstrated that VIPR bound
avidly to the immobilized lectin WGA [5,7]. We are
now showing that the OG-solubilized VIP receptor
can be precipitated by free WGA and functionally
reconstituted by displacing the lectin with the trisac-
charide TAC. To our knowledge this is the ¢rst time
that a lectin precipitation technique is used to recon-
stitute membrane vesicles. Attempts to reconstitute
VIPR using common techniques and di¡erent mix-
tures of exogenous lipids have met with little or no
success. The successful reconstitution of active VIP
receptors described in this report was probably de-
pendent on the combination of OG as detergent and
WGA as a tool to aggregate membrane glycoproteins
and their associated lipids. In preliminary experi-
ments the WGA/TAC reconstitution method was
tested with other detergents such as Tween 20, Triton
X-100 and CHAPS. All these detergents could solu-
bilize active VIPR to a certain extent but OG was, by
far, the most e¡ective with respect to solubilization,
lectin aggregation, lipid vesicle formation and VIPR
functionality, suggesting that the other detergents ei-
ther caused a conformational change in the VIPR or
were more delipidating agents (data not shown). The
procedure described herein allowed us to recover
more than 96% of VIPR with a slight increase in
VIP binding parameters (see Kd values and Bmax),
as well as a typical rank order of potency for VIP-
related peptides.
Since VIPR contains seven putative transmem-
brane domains, one could reasonably assume that
receptors become automatically incorporated as inte-
gral proteins upon vesicle formation. Nevertheless, it
Fig. 10. SDS-PAGE of PNGase F-treated VIPR. After cross-
linking with 125I-VIP, IGR 39 cells were either directly treated
with 100 U/ml of PNGase F for 3 h at 37‡C, or solubilized
with OG and reconstituted by the WGA/TAC technique. The
reconstituted 125I-VIP-labeled vesicles were then treated with
PNGase F under the same conditions. Control samples did not
receive the enzyme. Reference protein size markers are indicated
on the left of the ¢gure.
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was of importance to rule out the possibility that
VIPR were merely adsorbed at the surface of the
liposomes. We demonstrated here that VIPR associ-
ated with the vesicles could only be removed by re-
solubilization in OG and not by high salt or alkaline
pH. Furthermore, two lines of evidence argue that
the reconstituted VIPR are oriented right side out:
(i) VIP binding activity was not increased by OG re-
solubilization of the TAC pellet and (ii) PNGase-F
treatment of vesicles completely de-N-glycosylated
the receptor.
Although aggregation of hydrophobic glycopro-
teins with WGA could be easily understood, the
process of lipid vesicle formation subsequent to the
removal of the lectin is not immediately apparent.
One likely explanation is that WGA-glycoprotein-lip-
id complexes may form a rigid network where lipid-
lipid interaction may not be facilitated. Hence, the
displacement of the lectin by TAC may ‘break’ cross-
links, leading to free movements of complexes and
increasing lipid-lipid interaction and vesicle forma-
tion. Furthermore, oligosaccharide moieties of the
reconstituted glycoconjugates may contribute to the
stability of the lipid vesicles and the maintenance of
the three-dimensional structure of membrane pro-
teins. Our studies were performed with a complex
mixture of lipids and proteins and the data do not
lend themselves to a detailed analysis of how a given
glycoprotein, such as VIPR, maintains its function.
Nevertheless, Moellerfeld et al. [26] have reported
that the stability of lipid membranes could be im-
proved by coating with polysaccharide derivatives
bearing hydrophobic anchor groups.
VIPR has been previously puri¢ed by Couvineau
et al. [27]. However, although the receptor was puri-
¢ed to homogeneity it was unable to bind VIP unless
the receptor was re-mixed with the £owthrough frac-
tions of the VIP a⁄nity column, suggesting that
without the other membrane constituents the VIPR
presumably undergoes a conformational change to a
state with an altered a⁄nity for VIP. Besides, it has
been shown that the conformation of the ligand VIP
itself could be modulated by interaction with mem-
brane phospholipids [28,29]. These data coupled with
the results of the present paper suggest that VIP-
VIPR interaction in target tissue may depend, in
part, on membrane phospholipid characteristics.
One could expect a successful functional WGA/
TAC reconstitution of a puri¢ed VIPR mixed with
host cell lipids. In this regard, we have found that the
recombinant VIPR from CHO cells behaved as the
native VIPR (from IGR 39 cells) with respect to
lectin precipitability and reconstitution (ongoing ex-
periments from our group). This ¢rst step is encour-
aging, especially using recombinant VIP receptors
which have been engineered (i.e., carrying a polyhis-
tidine tag) to facilitate their puri¢cation. Moreover,
transfected cells expressing engineered VIPR may
provide a feasible system to complete our studies
on structure-function relationship of VIPR glycosyl-
ation. For instance, addition of particular sugars
such as sialic acid or fucose by co-transfection of
VIPR cDNA with speci¢c glycosyltransferase
cDNAs may provide an interesting system where ter-
minal glycosylation would be controlled to allow pre-
cipitation/reconstitution with speci¢c lectins.
Other membrane receptors such as the integrins
KvL5 and KvL6, the L-adrenergic and the IGF-1 (in-
sulin-like growth factor-1) receptors have been func-
tionally reconstituted using this procedure (data not
shown). The remarkable stability of the WGA/TAC
reconstituted receptors (several days at 4‡C and up
to 24 h at room temperature) is an additional factor
which may contribute to lighten experiments in cell
adhesion and ligand-receptor assays.
This ¢rst successful functional reconstitution of
VIP receptors is a step towards its puri¢cation and
now permits further investigation of receptor struc-
ture and function.
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